ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Breast neoplasm
Figure 1
ABCIC
Original Article

Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?

André Luiz Cerqueira de Almeida et al. Edval Gomes dos Santos Júnior Aluísio José de Oliveira Monteiro Neto Thyago Monteiro do Espírito Santo … Paulo André A. Almeida Samuel Oliveira Affonseca Caroline de Souza Almeida Matheus Pamponet Freitas Cecília Lopes Viana Santos Vitória Régia Beserra Barbosa Ximenes Mariana Andrade Falcão Israel Costa Reis Suzane Pereira de Souza Maurício Gomes da Silva Serra Ana Beatriz Menezes de Oliveira Tayla Silva Santos Nilson Lima Lopes Marcelo Dantas Tavares de Melo

Abstract

Background:

The combination of doxorubicin (DOX) with paclitaxel (PTX) effectively treats breast cancer (BC). However, DOX-associated cardiotoxicity (CTX) is aggravated by the use of PTX. Consensus is lacking about which drug sequence involves the most CTX.

Objectives:

To evaluate whether DOX followed by PXT or the reverse sequence has the greatest cardiotoxic potential in the treatment of BC.

Methods:

Prospective study of women with primary BC who received four cycles of DOX and 12 infusions of PTX. Participants were divided into Group 1 (G1; PXT before DOX) and Group 2 (G2; DOX before PXT) at the discretion of the oncologist. CTX was defined as an absolute reduction in left ventricular ejection fraction (LVEF) > 10% to a value <53%. Patients underwent clinical evaluations and echocardiography before treatment (Phase 1) and one year after treatment (Phase 2).

Results:

Sixty-nine women were evaluated: 19 in G1 and 50 in G2. The groups had similar clinical characteristics. The doses of radiation, DOX, and PTX used were similar. Eight (11.6%) patients developed CTX: two (10.5%) in G1 and six (12.0%) in G2 (p=0.62). The mean LVEF was similar between groups in Phase 1 (G1=65.1±3.5%; G2=65.2±3.9%; p=0.96), with a significant reduction noted after one year in both groups: G1=61.4±8.1% (p=0.021) and G2=60.8±7.6% (p<0.001). Although lower, mean LVEF remained similar between groups after Phase 2 (p=0.79).

Conclusions:

In women with BC who underwent chemotherapy, the incidence of CTX at the end of the first year of treatment was similar regardless of whether DOX was used before or after PTX.

  • Breast neoplasm
  • Cardiotoxicity
  • Doxorubicin
  • Paclitaxel
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
13/06/2022 DOI: 10.47593/2675-312X/20223502eabc289 Views 3

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Almeida ALC, Santos Júnior EG, Monteiro Neto AJO, Santo TME, Almeida PAA, Affonseca SO, Almeida CS, et al. Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular 2022;35(2):eabc289.

Electronic Document Format (ABNT)

Almeida, André Luiz Cerqueira de; Santos Júnior, Edval Gomes dos; Monteiro Neto, Aluísio José de Oliveira; Santo, Thyago Monteiro do Espírito; Almeida, Paulo André A.; Affonseca, Samuel Oliveira; Almeida, Caroline de Souza; Freitas, Matheus Pamponet; Santos, Cecília Lopes Viana; Ximenes, Vitória Régia Beserra Barbosa; Falcão, Mariana Andrade; Reis, Israel Costa; Souza, Suzane Pereira de; Serra, Maurício Gomes da Silva; Oliveira, Ana Beatriz Menezes de; Santos, Tayla Silva; Lopes, Nilson Lima; Melo, Marcelo Dantas Tavares de. Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular, v. 35, n. 2, eabc289, Jun. 2022.

Electronic Document Format (APA)

Almeida, A. L. C. , Santos Júnior, E. G. , Monteiro Neto, A. J. O., Santo, T. M. E., Almeida, P. A. A., Affonseca, S. O., Almeida, C. S., Freitas, M. P., Santos, C. L. V., Ximenes, V. R. B. B., Falcão, M. A., Reis, I. C., Souza, S. P. , Serra, M. G. S., Oliveira, A. B. M. , Santos, T. S., Lopes, N. L., & Melo, M. D. T. (2022). Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular, 35(2), eabc289.

Electronic Document Format (ISO)

Almeida, André Luiz Cerqueira de and Santos Júnior, Edval Gomes dos and Monteiro Neto, Aluísio José de Oliveira and Santo, Thyago Monteiro do Espírito and Almeida, Paulo André A. and Affonseca, Samuel Oliveira and Almeida, Caroline de Souza and Freitas, Matheus Pamponet and Santos, Cecília Lopes Viana and Ximenes, Vitória Régia Beserra Barbosa and Falcão, Mariana Andrade and Reis, Israel Costa and Souza, Suzane Pereira de and Serra, Maurício Gomes da Silva and Oliveira, Ana Beatriz Menezes de and Santos, Tayla Silva and Lopes, Nilson Lima and Melo, Marcelo Dantas Tavares de. Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular [online]. 2022, vol. 35, n. 2, [cited 2026-10-14], eabc289. Available from: <https://journals.cardiol.br/en/article/is-paclitaxel-less-cardiotoxic-in-the-treatment-of-breast-cancer-before-or-after-doxorubicin/>. ISSN 2318-8219

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News